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Post-bronchiolitis wheezing is 
associated with toll-like receptor 9 
rs187084 gene polymorphism
Kirsi Nuolivirta1,*, Sari Törmänen2,*, Johanna Teräsjärvi3, Juho Vuononvirta3, Petri Koponen2, 
Matti Korppi2, Merja Helminen2, Ville Peltola4 & Qiushui He3,5,*
Innate immunity receptors play a critical role in host defence, as well as in allergy and asthma. The aim 
of this exploratory study was to evaluate whether there are associations between TLR7 rs179008, TLR8 
rs2407992, TLR9 rs187084 or TLR10 rs4129009 polymorphisms and viral findings, clinical characteristics 
or subsequent wheezing in infants with bronchiolitis. In all, 135 full-term infants were hospitalized 
for bronchiolitis at age less than 6 months: 129 of them were followed-up until the age of 1.5 years. 
The outcome measures were repeated wheezing, use of inhaled corticosteroids, atopic dermatitis 
during the first 1.5 years of life and total serum immunoglobulin E (IgE). There were no significant 
associations between the genotypes or allele frequencies of TLR7 rs179008, TLR8 rs2407992, TLR9 
rs187084 or TLR10 rs4129009 polymorphisms and clinical characteristics or the severity of bronchiolitis 
during hospitalization. During follow-up, repeated wheezing was more common in children with TLR9 
rs187084 variant genotype CC (30.5%) than in children with TLR9 wild-type genotype TT (12.2%) 
(p = 0.02, aOR 2.73, 95% CI 1.02–7.29). The TLR10 rs4129009 minor allele G was associated with 
elevated total serum IgE. TLR9 rs187084 gene polymorphism may be associated with post-bronchiolitis 
wheezing, and TLR10 rs4129009 gene polymorphism may be associated with atopy.
Bronchiolitis is the most common lower respiratory tract infection (LRTI) in young children1. Among the various 
respiratory viruses causing bronchiolitis, respiratory syncytial virus (RSV) is the single most important one2. The 
clinical course of primary RSV infection is highly variable, and genetic variations in genes regulating the immune 
response evidently are important in determine whether a child suffers from a mild upper respiratory infection or 
a more severe LRTI- like bronchiolitis after exposure to RSV3.
Bronchiolitis in infancy is associated with subsequent wheezing in early childhood4. The mechanisms of 
virus-induced wheezing and the role of airway hyper-responsiveness, however, are poorly understood. Signalling 
via toll-like receptors (TLRs) seems to play an important role in triggering airway inflammation5,6.
TLRs are key molecules in innate immunity that detect conserved structures, which are present in a broad 
range of pathogens, and either promote or inhibit inflammatory and immune responses7. TLR3, TLR7, TLR8 and 
TLR9 recognize viral products responding to viral double-stranded (ds) RNA, viral single-stranded (ss) RNA or 
cytotoxic granule proteins containing DNA from certain bacteria and some viruses, respectively8,9. TLR10 is, in 
addition to TLR1, TLR2 and TLR6, a member of the TLR2 subfamily. Although TLR10 is a pattern-recognition 
protein without known ligand specificity, there is evidence that it is a modulatory receptor with mainly inhibitory 
properties10.
It has been reported that genetic factors might influence susceptibility to RSV infection in early life. TLR4 gene 
polymorphisms have been associated with severe RSV infection11,12. In addition, TLR9 and TLR10 gene polymor-
phisms13 and TLR 3 gene polymorphisms14 were associated with RSV bronchiolitis.
As the innate immune system is an important link between environmental exposure and the regulation 
of cytokine responses, alterations in innate immunity may be fundamental to the balance between Th1- and 
Th2-oriented responses and to the subsequent development of asthma and allergy. In a recent review on the 
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relationship between genes encoding TLRs and asthma risk, an association was found between TLR9 gene poly-
morphisms and asthma15. There is more evidence that polymorphisms in the TLR7 and TLR8 genes are related to 
asthma and allergy16–18, as well as to susceptibility to respiratory viral infections19,20.
We have prospectively followed-up a group of children hospitalized for bronchiolitis at age less than 6 months. 
We have earlier studied the TLR1rs5743618, TLR2 rs5743708, TLR3 rs3775291, TLR4 rs4986790 and TLR6 
rs5743810 polymorphisms, and reported their associations with bronchiolitis and post-bronchiolitis outcomes. 
The aim of the present study was to complement this exploratory study series by evaluating whether the TLR7 
rs179008, TLR8 rs2407992, TLR9 rs187084 and TLR10 rs4129009 polymorphisms are associated with the pres-
ence, clinical characteristics and viral etiology of bronchiolitis in early infancy. In addition, we studied whether 
there are associations between these polymorphisms and post-bronchiolitis outcomes including subsequent 
infections, post-bronchiolitis wheezing, need for corticosteroid treatment and atopic manifestations until the age 
of 1.5 years.
Results
Cases versus controls. The genotypes and allele frequencies of cases (children hospitalized with bron-
chiolitis) and controls (healthy children from a birth cohort study) did not differ substantially with respect to 
TLR7 rs179008, TLR8 rs2407992, TLR9 rs187084 or TLR10 rs4219009 polymorphisms (Table 1). Because TLR7 
rs179008 and TLR8 rs2407992 are located on the X chromosome, the data are given separately for boys and girls. 
The studied alleles of TLR9 and TLR10 were in HWE. Because TLR7 and TLR8 genes are located on the X chro-
mosome, HWE was not studied.
Hospitalization in infancy. The mean age of the 135 bronchiolitis patients was 10.0 weeks (range 1–25 
weeks, SD 6.94) during hospitalization. The study included 65 (48.1%) boys (Table 2). The causative virus was 
RSV in 101 (74.8%) cases and rhinovirus in 11 (8.1%) cases. Influenza A virus was found in 7 (5.2%) and human 
metapneumovirus in 2 (1.5%) cases, and parainfluenzavirus type 3 (PIV3) was found in 1 (0.8%) case. Two differ-
ent viruses were detected in 8 (5.9%) samples: rhinovirus and adenovirus in two, and rhinovirus and bocavirus in 
two samples, and RSV and adenovirus, RSV and bocavirus, Influenza A and bocavirus, and PIV3 and adenovirus, 
each in one sample. There were no differences in the clinical picture or in the outcomes between cases with multi-
ple viruses vs. a single virus detected. The sample was negative for studied viruses in 13 (9.6%) cases.
Genotypes and allele frequencies Cases, No. (%) Controls, No. (%)
TLR7 females AA 43/70 (61.4) 77/145 (53.1)
TLR7 females AT 23/70 (32.9) 53/145 (36.6)
TLR7 females TT 4/70 (5.7) 15/145 (10.3)
TLR7 females, major allele A 109/140 (77.9) 207/290 (71.4)
TLR7 females, minor allele T 31/140 (22.1) 83/290 (28.6)
TLR7 males, allele A present 54/65 (83.1) 116/168 (69.0)
TLR7 males, allele T present 11/65 (16.9) 52/168 (31.0)
TLR8 females GG 19/70 (27.1) 43/144 (29.8)
TLR8 females GC 41/70 (58.6) 70/144 (48.6)
TLR8 females CC 10/70 (14.3) 31/144 (21.6)
TLR8 females, major allele G 79/140 (56.4) 156/288 (54.2)
TLR8 females, minor allele C 61/140 (43.6) 132/288 (45.8)
TLR8 males, allele G present 32/65 (49.2) 89/168 (53.0)
TLR8 males, allele C present 33/65 (50.8) 79/168 (47.0)
TLR9 TT 42/133 (31.6) 87/270 (32.0)
TLR9 TC 55/133 (41.4) 130/270 (48.0)
TLR9 CC 36/133 (27.1) 53/270 (20.0)
TLR9 major allele T 139/266 (52.3) 304/540 (56.3)
TLR9 minor allele C 127/266 (47.7) 236/540 (43.7)
TLR10 AA 113/135(83.7) 271/328 (82.6)
TLR10 AG 21/135 (15.6) 47/328 (14.4)
TLR10 GG 1/135 (0.7) 10/328 (3.0)
TLR10 major allele A 247/270 (91.5) 589/656 (89.8)
TLR10 minor allele G 23/270 (8.5) 67/656 (10.2)
Table 1.  The genotypes and allele frequencies of TLR7 rs179008 (171 A/T), TLR8 rs2407992 (2040 C/G), 
TLR9 rs187084 (1486 T/C) and TLR10 rs4219009 (2322 A/G) in the bronchiolitis patients (cases) and 
population-based controls. The test showed heterozygosis of the TLR7 gene in four controls and heterozygosis 
of the TLR8 gene in four controls, although the subjects were male. In one male control, the test results showed 
heterozygosis of both TLR7 and TLR8. These seven controls were deleted from the analyses. There were no 
statistically significant differences between cases and controls.
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There were no significant associations between the TLR7 rs179008 or TLR8 rs4207992 genotypes or allele 
frequencies and the clinical characteristics of bronchiolitis in females (Table 3). Instead, the presence of the minor 
allele T in the TLR7 rs179008 gene in males was associated with the RSV aetiology of bronchiolitis (100% vs. 
70.4% in those with the major allele A) and with the need for feeding support (54.5% vs. 24.1%, respectively) 
(Table 4). The viral aetiology of bronchiolitis, and the need for feeding support or oxygen supplementation during 
bronchiolitis hospitalization did not differ between the children with different genotypes or allele frequencies 
of TLR9 rs187084 or TLR10 rs4219009 (Table 5). The LOS in hospital was roughly equal in all the groups con-
structed on the basis of TLR7 rs179008, TLR8 rs4207992, TLR9 rs187084 or TLR10 rs4219009 polymorphisms.
Follow-up for 1.5 years. In all, 129 toddlers attended the follow-up visit at the mean age of 18.1 months 
(range 13–25 months, SD 2.35). There were 24 (19.4%) children who had presented with repeated wheezing 
(≥ 2 episodes) during the follow-up period and 16 (12.4%) children who had used inhaled corticosteroids (ICSs). 
Parents reported that 30 children (23.3%) had doctor-diagnosed food allergy and 18 children (14.0%) had 
doctor-diagnosed atopic dermatitis during the first 1.5 years of life (Table 2). In addition, 63 children (48.8%) had 
suffered from recurrent (≥ 3) otitis media. Total serum IgE was measured from 125 children: among them, the 
mean total serum IgE was 43.4 IU/ml (SD 95.9, range 1–621).
In males, the presence of the TLR8 minor allele C was associated with recurrent otitis media, which was pres-
ent in 22 (68.8%) of the 32 minor allele C carriers vs. in 13 of the 33 (39.4%) major allele G carriers (p = 0.04) 
(Table 6). However, the significance of this association was lost when adjusted for age (OR 2.75, 95% CI 0.96–
7.85). In females, the result was of the same direction but not statistically significant (p = 0.06) (Table 7). There 
was a non-significant finding that the TLR7 major allele A, when present as homozygous, was connected to recur-
rent otitis media in females (p = 0.07) (Table 7), but this was not seen in males (Table 6).
Infants during bronchiolitis N = 135
Age (mean, range, SD) 10.0 weeks (1–25, SD 6.94)
Boys N(%) 65 (48.1)
RSV N (%) 101 (74.8)
Feeding support N (%) 45 (33.3)
Oxygen supplementation N(%) 25 (18.5)
Length of hospital stay (mean, range, SD) 4.74 days (0–22, Sd 4.74)
Children at follow-up visit N = 129
Age (mean, range, SD) 18.1 months (13–25, SD 2.35)
Boys 62 (48.1)
Post-bronchiolitis wheezing N (%) 24 (19.4)
Inhaled corticosteroids 16 (12.4)
Food allergy 30 (23.3)
Atopic dermatitis 18 (14.0)
Table 2.  Clinical characteristics of the bronchiolitis population during hospitalization and follow-up visit 
at the mean age of 1.5 years.
TLR7 females N = 70
AA  
N = 43, No. (%)
AT  
N = 23, No. (%)
TT  
N = 4, No. (%)
Major allele A 
N = 109, No. (%)
Virus RSV N = 52 34 (79.1) p = 0.19 15 (65.2) 3 (75.0) p = 0.73 83 (76.1) p = 0.71
Oxygen required 
N = 16 9 (20.9) p = 0.42 6 (26.1) 1 (25.0) p = 0.67 24 (22.0) p = 0.73
Feeding support 
N = 28 19 (67.9) p = 0.26 7 (30.4) 2 (50.0) p = 0.53 45 (41.3) p = 0.70
LOS, mean in days 
(standard deviation) 5.4 (SD 3.7) p = 0.51 5.0 (SD 3.0) 4.0 (SD 1.8) p = 0.48
TLR8 females N = 70 GG N = 19, No. (%) GC N = 41, No. (%) CC N = 10, No. (%) Major allele G N = 79, No. (%)
Virus RSV N = 52 14 (73.7) p = 0.59 30 (73.2) 8 (80.0) p = 0.50 58 (73.4) p = 0.92
Oxygen required 
N = 16 5 (26.3) p = 0.45 10 (24.4) 1 (10.0) p = 0.28 20 (25.3) p = 0.56
Feeding support 
N = 28 9 (47.4) p = 0.31 15 (36.4) 4 (40.0) p = 0.64 33 (41.8) p = 0.75
LOS, mean in days 
(standard deviation) 4.9 (SD 2.1) p = 0.69 5.4 (SD 3.9) 4.8 (SD 3.4) p = 0.72
Table 3.  Genotypes and major allele frequencies of TLR7 rs179008 and TLR8 rs2407992 genes in 70 female 
patients in relation to clinical characteristics of bronchiolitis. The length of hospital stay (LOS) was mean 5.2 
days (SD 3.4, range 1–25) in all 70 cases. Major allele vs minor allele.
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Former bronchiolitis patients with the homozygous variant TLR9 rs187084 genotype CC had repeated wheez-
ing more often (30.5%, p = 0.02) than children with the wild-type genotype TT (12.2%) during the follow-up 
period until the age of 1.5 years (Table 8). The OR was 2.66 (95% CI 1.01–7.06) when adjusted for age and sex, 
and 2.73 (95% CI 1.02–7.29) when adjusted further for atopic dermatitis. There were no significant associations 
between TLR7 rs179008, TLR8 rs2407992 or TLR10 rs4219009 gene polymorphisms and repeated wheezing.
Children with TLR10 rs4219009 genotype AG (no child had the GG genotype) had more often had elevated 
total serum IgE than children with TLR10 genotype AA (Table 7). The OR was 3.79 (95%CI 1.25–11.56) when 
adjusted for age and sex. There were no significant associations between TLR7 rs179008, TLR8 rs2407992 or TLR9 
rs187084 gene polymorphisms and total serum IgE, food allergy or atopic dermatitis during the first 1.5 years of life.
Discussion
Our study was an exploratory study on the possible association between the TLR7 rs179008, TLR8 rs4207992, 
TLR9 rs187084 or TLR10 rs4219009 gene polymorphisms and characteristics of bronchiolitis in early infancy 
or post-bronchiolitis outcomes. The main result was that the TLR9 rs187084 polymorphism was associated with 
repeated wheezing until the age of 1.5 years after bronchiolitis at age less than 6 months. One-third of children 
who were homozygous for the variant genotype CC had suffered from repeated wheezing, compared to 12.2% 
of other former bronchiolitis patients. Another important result was that the TLR10 rs4219009 minor allele G 
was associated with elevated total serum IgE in infancy. However, such associations were not seen in the case of 
clinical findings, i.e., food allergy or atopic dermatitis during the first 1.5 years of life. Both these results remained 
significant when adjusted for the most important confounders. In addition, we revealed a preliminary association 
between the presence of the TLR8 rs4207992 minor allele C and recurrent otitis media in males but not in females.
However, polymorphisms TLR7 rs179008, TLR8 rs4207992, TLR9 rs187084 and TLR10 rs4219009 were not 
associated with the characteristics of bronchiolitis, including those reflecting bronchiolitis severity. All patients 
TLR7 males  
N = 65
A present  
N = 54, No. (%)
T present  
N = 11, No. (%)
Virus RSV N = 49 38 (70.4) p = 0.03 11 (100)
Oxygen required N = 9 6 (11.1) p = 0.71 3 (27.3)
Feeding support N = 19 13 (24.1) p = 0.05 6 (54.5)
LOS, mean in days 
(standard deviation) 4.0 (SD 2.7) p = 0.06 5.8 (SD 3.7)
TLR8 males N = 65 G present N = 32 (%) C present N = 33 (%)
Virus RSV N = 49 26 (81.3) p = 0.21 23 (69.7)
Oxygen required N = 9 6 (18.8) p = 0.22 3 (9.1)
Feeding support N = 19 9 (28.1) p = 0.53 10 (30.3)
LOS, mean in days 
(standard deviation) 4.1 (SD 3.2) p = 0.69 4.4 (SD 2.7)
Table 4.  Genotypes and major allele frequencies of TLR7 rs179008 and TLR8 rs2407992 genes in 65 male 
patients in relation to the clinical characteristics of bronchiolitis. The length of hospital stay (LOS) was mean 
4.3 days (SD 3.0, range 0–15) in all 65 cases.
TLR9 N = 133
TT  
N = 42, No. (%)
CT  
N = 55, No. (%)
CC  
N = 36, No. (%)
Major allele T 
N = 139, No. (%)
Virus RSV N = 99 33 (78.6) p = 0.78 39 (70.9) 27 (75.0) p = 0.97 105 (75.5) p = 0.87
Oxygen required 
N = 25 7 (16.7) p = 0.43 13 (23.6) 5 (13.9) p = 0.27 27 (19.4) p = 0.82
Feeding support 
N = 45 14 (33.3) p = 0.55 21 (38.9) 10 (27.8) p = 0.25 49 (35.3) p = 0.72
LOS, mean in days 
(standard deviation) 5.10 (SD 3.80) p = 0.85 4.45 (SD 2.41) 4.61 (SD 3.58) p = 0.34
TLR10 N = 135 AA N = 113, No. (%) AG N = 21, No. (%) GG N = 1, Major allele A N = 247, No. (%)
Virus RSV N = 101 84 (74.3) p = 0.50 16 (76.2) 1 184 (74.5) p = 0.
Oxygen required 
N = 25 22 (19.5) p = 0.38 2 (9.5) 1 46 (18.6) p = 0.
Feeding support 
N = 47 40 (35.4) p = 0.48 6 (28.6) 1 86 (34.8) p = 0.
LOS, mean in days 
(standard deviation) 4.74 SD 3.25 p = 0.94 4.52 SD 3.04 NC
Table 5.  Genotypes and major allele frequencies of TLR9 rs187084 (N = 133) and TLR10 rs4219009 
(N = 135) genes in bronchiolitis patients in relation to the clinical characteristics of bronchiolitis. The 
length of hospital stay (LOS) was mean 4.7 days (SD 3.2, range 0–22) in all 133 cases. NC not calculated. Major 
allele vs minor allele.
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with bronchiolitis required hospitalization; one-fourth received supplementary oxygen; one-third required 
feeding support during hospitalization. Viruses such as RSV are recognized after invasion of the cells by those 
viral-sensing TLRs and other pattern-recognizing proteins, which are located within endosomes21.
In previous studies, TLR4 gene polymorphisms have been associated with RSV infections11, and there is pre-
liminary evidence that TLR3 gene polymorphism14, and TLR9 and TLR10 gene polymorphisms as well11,13, may 
be associated with RSV bronchiolitis. In this exploratory study, bronchiolitis cases and population-based controls 
did not differ significantly for genotypes or allele frequencies of TLR7 rs179008, TLR8 rs4207992, TLR9 rs187084 
and TLR10 rs4219009 polymorphisms.
In a recent systematic review and meta-analysis, TLR9 rs5743836 gene polymorphism was associated with 
increased asthma risk15. TLR9 recognizes bacterial and viral CpG-DNA22. In an experimental study, the 1237 
T/C single nucleotide polymorphisms (SNP) of TLR9 rs5743836 generated a functional IL-6 response element. 
Mononuclear cells carrying this SNP, when exposed to IL-6, responded by producing more TLR9, which then 
exacerbated the cellular response to the TLR9 ligand CpG23. IL-6 is a pro-inflammatory cytokine that may 
contribute to impaired lung function in allergic asthma24. In another study, the TLR9 rs5743836 variant gen-
otype was associated with diminished lung function and chronic obstructive pulmonary disease (COPD)25. 
This effect was thought to be caused by alveolar macrophage dysfunction. However, there were no associations 
with TLR9 rs187084 SNPs25. Nonetheless, TLR9 rs187084 polymorphism as applied in this study has also been 
shown to be functional26, being associated with immunity against certain infectious diseases such as tubercu-
losis and malaria26. Moreover, that polymorphism was associated with airway hyper-responsiveness in four 
population-based samples from Canada and Australia27. In our present study, the TLR9 rs187084 polymorphism 
was associated with repeated post-bronchiolitis wheezing. In this same cohort, TLR3 rs3775291 gene polymor-
phism was associated with repeated wheezing after bronchiolitis in infancy14.
The association of the TLR10 gene with asthma has been documented in European-American populations28. 
Two-thirds of children who have repeated post-bronchiolitis wheezing until the age of two years are “transient 
wheezers” which means that they will grow out of their wheezing tendency by or at school age29. The risk of aller-
gic asthma that is associated with the TLR10 gene polymorphism28 was minor in our patients with bronchiolitis 
in early infancy. However, we found an association between TLR10 rs4219009 gene polymorphism and elevated 
total serum IgE, and based on many studies, atopy and atopic sensitization are well-known risk factors of allergic 
asthma, in post-bronchiolitis cohorts as well30.
TLR7 rs179008 and TLR8 rs4207992 gene polymorphisms, located on the X chromosome, were not associated 
with post-bronchiolitis outcome measures in either boys or girls. In earlier studies, TLR7 and TLR8 polymor-
phisms were associated with asthma and allergic rhinitis16,17. Our finding is in disagreement with the results of a 
previous study16, in which the TLR8 rs4207992 gene polymorphism, also used in the present study, was associated 
with asthma, atopic dermatitis, allergic rhinitis and elevated serum allergen-specific IgE. In experimental studies, 
concomitant TLR7 gene deficiency and early Pneumovirus infection predisposed mice toward the development 
of asthma-like pathology20. In the present cohort, 19.4% of children suffered from repeated post-bronchiolitis 
virus-induced wheezing until 1.5 years of age. However, allergic asthma may develop later in childhood, even 
after many symptom-free years29.
There were certain limitations in the present study. The number of patients was relatively small for a genetic 
study. The small number of patients meant a risk of type-2 statistical errors. On the other hand, we carried 
out multiple analyses for polymorphisms of four different TLR encoding genes, which risked type-1 statistical 
errors. Because the data on TLR7, TLR8, TLR9 and TLR10 genes as risk factors for bronchiolitis, early-childhood 
wheezing and childhood asthma are mainly lacking, our study was an exploratory one with no purpose to test 
TLR7 males Outcome variables, 
N = 62
A present 
N = 54, No. (%)
T present  
N = 11, No. (%)
Repeated (≥ 2 episodes) wheezing 
N = 15 14 (27.4) p = 0.19 1 (9.1)
Inhaled corticosteroids N = 11 10 (19.6) p = 0.37 1 (9.1)
Atopic dermatitis N = 10 10 (19.6) p = 0.12 0
Food allergy N = 15 11 (21.6) p = 0.25 4 (36.4)
IgE ≥ 60 N = 10/59 8 (15.7) p = 0.60 2 (18.2)
Recurrrent (≥ 3) otitis media N = 35 26 (50.9) p = 0.06 9 (81.8)
TLR8 males Outcome variables, 
N = 62
G present 
N = 30, No. (%)
C present N = 32, 
No. (%)
Repeated (≥ 2 episodes) wheezing 
N = 15 5 (16.7) p = 0.15 10 (31.3)
Inhaled corticosteroids N = 11 3 (10.0) p = 0.11 8 (25.0)
Atopic dermatitis N = 10 2 (6.7) p = 0.05 8 (25.0)
Food allergy N = 15 7 (23.3) p = 0.56 8 (25.0)
IgE ≥ 60 N = 10/59 3 (10.0) p = 0.19 7 (21.9)
Recurrrent (≥ 3) otitis media N = 35 13 (39.4) p = 0.04 22 (68.8)
Table 6.  Genotypes and major allele frequencies of TLR7 rs179008 and TLR8 rs2407992 genes in 62 male 
bronchiolitis patients in relation to outcome variables during the post-bronchiolitis follow-up until the age 
of 1.5 years.
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hypotheses, but rather to produce hypotheses for later confirmatory studies31,32. Therefore, we did not make any 
statistical multiplicity corrections. The main results were confirmed with multivariate tests adjusted for the most 
important confounding factors.
The strengths of the present study were the prospective design, an extensive virological test panel available 
during hospitalization for bronchiolitis and careful data collection during bronchiolitis and at the subsequent 
control visit including e.g. daily diaries recordings by parents. The homogeneity of study populations, as in the 
present study, is a clear benefit in genetic studies.
In conclusion, we found preliminary evidence that TLR9 polymorphisms may be associated with 
post-bronchiolitis wheezing. This finding needs to be confirmed or ruled out in subsequent confirmatory studies.
Methods
Bronchiolitis patients. Previously healthy, full-term infants hospitalized for bronchiolitis at less than 6 
months of age during the period December 1, 2001 through May 31, 2002 and during the period from October 
28, 2002 through May 31, 2004 were enrolled in the study. In all, 187 eligible infants were hospitalized for the first 
time during the two study periods. Appropriate clinical data including viral findings and gene polymorphisms 
were available from 135 infants33. Bronchiolitis was defined as an acute LRTI characterized by rhinorrhea, cough, 
and diffuse wheezes and/or crackles1. The viral aetiology of bronchiolitis was studied by antigen detection and 
polymerase chain reaction (PCR) in nasopharyngeal aspirates (NPA), as described recently33. The studied viruses 
were RSV, human rhinovirus (hRV), human metapneumovirus (hMPV), InfluenzaA virus, Parainfluenza3 virus 
(PIV3), adenovirus and human bocavirus (hBoV). Data on disease severity, such as the need for supplementary 
oxygen and feeding support, and the length of hospital stay (LOS) were recorded during the inpatient care33. 
Supplementary oxygen was given when oxygen saturation (SaO2) measured with pulse-oximetry was less than 
94%, and feeding support was defined as a need for intravenous fluids or feeding via a nasogastric tube.
After hospitalization for bronchiolitis, the children were invited to a follow-up visit at 1.5 years of age (on average), 
and 129 (92.8% of those invited; 69.0% of those hospitalized) attended. At the follow-up visit, the parents were 
interviewed using a structured questionnaire on the occurrence of otitis media, and wheezing episodes, the pre-
scription of antibiotics, and the use of corticosteroids for wheezing after hospitalization for bronchiolitis34. The 
parents had recorded a diary during the 1.5 years post-bronchiolitis follow-up period, including descriptions of 
all infections and wheezing periods verified by a family doctor or a paediatrician. The study physician and the 
parents checked together the diaries at the control visit. The doctor-diagnosed episodes were recorded for the 
analyses.
Food allergy and atopic dermatitis, although reported by parents, were registered during hospitalization and 
at the control visit on average 1.5 years later—only doctor-diagnosed cases were included. A blood sample for 
immunoglobulin E (IgE) measurement was taken at the follow-up visit at the age of 1.5 years. Total serum IgE was 
determined by electro-chemiluminescence (ECLIA, Roche Diagnostics GmbH, Mannheim, Germany) according 
to laboratory practice. Serum IgE was considered to be elevated if the concentration was more than + 2SD above 
the mean of non-atopic Finnish children (> 60 IU/ml)35. Corticosteroid treatment meant maintenance medica-
tion periods with inhaled corticosteroids (ICSs) for repeated wheezing or suspected asthma. Repeated wheezing 
was defined as two or more wheezing episodes during the post-bronchiolitis follow-up period.
Frozen whole-blood samples were available for TLR7 rs179008, TLR8 rs2407992, and TLR10 rs4129009 geno-
typing from all 129 children. Samples for TLR9 rs187084 genotyping were available from 127 children.
TLR7 females Outcome variable, 
N = 67
AA  
N = 42, No. (%)
AT  
N = 21, No. (%)
TT  
N = 4, No. (%)
Major allele A 
N = 105, No. (%)
Repeated (≥ 2 episodes) wheezing 
N = 9 4 (9.5) p = 0.20 5 (23.8) 0 p = 0.55 13 (12.4) p = 1.0
Inhaled corticosteroids N = 5 2 (4.8) p = 0.27 3 (14.3) 0 p = 0.73 7 (6.7) p = 0.69
Atopic dermatitis N = 8 4 (9.5) p = 0.34 2 (9.5) 2 (50.0) p = 0.07 10 (9.5) p = 0.16
Food allergy N = 15 12 (28.6) p = 0.10 3 (14.3) 0 p = 0.35 27 (25.7) p = 0.20
IgE ≥ 60 N = 10/65 4 (9.5) p = 0.12 6 (28.6) 0 p = 0.60 14 (14.3) p = 0.41
Recurrrent (≥ 3) otitis media 
N = 28 21 (50.0) p = 0.07 6 (28.6) 1 (25.0) p = 0.44 48 (46.7) p = 0.24
TLR8 females Outcome variable, 
N = 67 GG N = 18, No. (%) GC N = 39, No. (%) CC N = 10, No. (%)
Major allele G 
N = 75, No. (%)
Repeated (≥ 2 episodes) wheezing 
N = 9 2 (11.1) p = 0.55 7 (17.9) 0 p = 0.21 10 (13.3) p = 0.62
Inhaled corticosteroids N = 5 2 (11.1) p = 0.41 3 (7.7) 0 p = 0.43 7 (9.3) p = 0.52
Atopic dermatitis N = 8 2 (11.1) p = 0.63 6 (15.4) 0 p = 0.25 10 (13.3) p = 0.62
Food allergy N = 15 3 (16.7) p = 0.37 11 (28.2) 1 (10.0) p = 0.29 17 (22.7) p = 0.94
IgE ≥ 60 N = 10/65 3 (16.7) p = 0.57 7 (17.9) 0 p = 0.20 13 (17.3) p = 0.45
Recurrrent (≥ 3) otitis media 
N = 28 8 (44.4) p = 0.50 14 (35.9) 6 (60.0) p = 0.18 30 (40.0) p = 0.76
Table 7.  Genotypes and major allele frequencies of TLR7 rs179008 and TLR8 rs2407992 genes in 67 female 
bronchiolitis patients in relation to outcome variables during the post-bronchiolitis follow-up until the age 
of 1.5 years. Major allele vs minor allele.
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Genetic studies. The genotyping of TLR8 rs2407992 (2040 C/G) was performed by pyrosequencing as 
described for TLR3 rs3775291 (1234 C/T)14. For TLR7 rs179008 (171 A/T), the PCR products were first purified 
using the QIA quick PCR Purification Kit (Qiagen, Hilden, Germany) according to the manufacturer’s protocol. 
PCR products with low deoxyribonucleic acid (DNA) content were eluted to 30 μ l of elution buffer. After purifi-
cation, the PCR products were pipetted to a 96-well plate (5 μ l) together with TLR7 rs179008 (171 A/T) forward 
primer (1.6 μ l). The 96-well plate was sent to the Institute for Molecular Medicine laboratory in Helsinki, Finland 
for sequencing. TLR9 rs187084 (1486 T/C) genotyping was performed using BspTI restriction enzyme (Thermo 
Fisher Scientific, Waltham, USA) for the digestion of PCR product36. High-resolution melting analysis (HMR) 
(Roche Diagnostics Light Cycler 480, Basel, Switzerland), was used to genotype TLR10 rs4129009 (2322 A/G) 
as described earlier36. The methods were described recently in more details36. The PCR and sequencing primers 
used for the TLR7, TLR8, TLR9, and TLR10 genes are described in Table 9. All the primers were purchased from 
Sigma-Aldrich, Finland.
Controls. TLR7 rs179008 and TLR8 rs2407992 polymorphisms were examined in two-month-old healthy 
Finnish infants, who participated in the Steps to Children’s Healthy Development and Wellbeing study (STEPS), 
which is a prospective birth cohort study of approximately 1,800 children37. No selection criteria were applied 
in the recruitment of children for the STEPS Study or for inclusion in the subgroup with TLR genotyping. DNA 
was extracted from blood collected at the age of two to three months in 412 subjects, who visited the study clinic 
in Turku, Finland37. Only 328 children were included as controls in the present study for TLR7rs 179008, TLR8 
rs2407992 and TLR10 rs 4129009 polymorphisms, due to the limited amount of DNA available from the infants 
who were not included. For TLR 9 rs187084, there was enough DNA to analyze only 270 samples. The genotyping 
processes were identical in the bronchiolitis cohort and in the controls, except for the TLR10 rs4129009 gene. 
Determination of that polymorphism was performed by digestion similarly to TLR9 rs187084 in the control 
group, and by HRMA in the bronchiolitis cohort.
Ethics. The study was carried out in accordance with the approved guidelines of the WMA Declaration of 
Helsinki. Before we enrolled the children we obtained informed parental consent, including the use of samples 
for genetic studies on bronchiolitis and asthma risk, both during hospitalization and at the control visit. The pro-
tocol of the study was approved by the Ethics Committee of the Tampere University Hospital District, Tampere, 
Finland. The personal data of the study subjects were not given to the two laboratories that performed the genetic 
studies, the National Institute of Health and Welfare, Turku, Finland, and the Institute for Molecular Medicine, 
Helsinki, Finland. The genotyping of control children was done within the STEPS study, which was carried out 
in accordance with the approved guidelines of the WMA Declaration of Helsinki. The protocol was approved by 
the Ethics Committee of the Hospital District of Southwest Finland, Turku, Finland. The parents of participating 
children provided their written, informed consent.
Statistical analyses. Data were analyzed using SPSS package version 23.0 (IBM Corp. NY, USA). Chi square 
and Fisher’s exact tests were used for categorized variables. Student’s t-test was used for normally distributed 
variables. The Mann–Whitney test was used for non-normally distributed continuous variables. The results were 
expressed as frequencies, proportional frequencies, means, medians and standard deviations (SD).
TLR9 Outcome variables, 
N = 127
TT  
N = 41, No. (%)
TC  
N = 53, No. (%)
CC  
N = 33, No.(%)
Major allele T 
N = 135, No.(%)
Repeated (≥ 2 episodes) wheezing 
N = 24 5 (12.2) p = 0.14 8 (15.1) 11 (30.5) p = 0.02 18 (13.3) p = 0.047
Inhaled corticosteroids N = 16 3 (7.3) p = 0.17 7 (13.2) 6 (18.2) p = 0.20 13 (9.6) p = 0.18
Atopic dermatitis N = 18 9 (22.0) p = 0.07 4 (7.5) 5 (15.2) p = 0.53 22 (16.3) p = 0.37
Food allergy N = 30 7 (17.1) p = 0.17 14 (26.4) 9 (27.3) p = 0.36 28 (20.7) p = 0.37
IgE ≥ 60 N = 20/123 7 (17.1) p = 0.46 7 (13.2) 6 (18.2) p = 0.46 21 (15.6) p = 0.94
Recurrrent (≥ 3) otitis media 
N = 62 22 (53.7) p = 0.29 21 (39.6) 19 (57.6) p = 0.17 65 (48.1) p = 0.89
TLR10 Outcome variables, 
N = 129 AA N = 109, No. (%) AG N = 19, No. (%) GG N = 1
Major allele A 
N = 237, No. (%)
Repeated (≥ 2 episodes) wheezing 
N = 24 20 (18.3) p = 0.54 4 (21.1) 0 44 (18.6) p = 0.78
Inhaled corticosteroids N = 16 13 (11.9) p = 0.47 3 (15.8) 0 29 (12.2) p = 0.73
Atopic dermatitis N = 18 16 (14.7) p = 0.44 2 (10.5) 0 34 (14.3) p = 1.0
Food allergy N = 30 27 (24.8) p = 0.26 3 (15.8) 0 57 (24.1) p = 0.59
IgE ≥ 60 N = 20/124 13(11.9) p = 0.015 7 (36.8) 0 33 (13.9) p = 0.08
Recurrrent (≥ 3) otitis media 
N = 63 54 (49.5) p = 0.45 9 (47.4) 0 117 (49.4) p = 0.84
Table 8.  Genotypes and major allele frequencies of TLR9 rs187084 (N = 127) and TLR10 rs4219009 
(N = 129) genes in bronchiolitis patients in relation to outcome variables during the post-bronchiolitis 
follow-up until the age of 1.5 years. Major allele vs. minor allele.
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Logistic regression was used for the multivariate analyses, adjusted for age, sex and atopic dermatitis during 
the first 1.5 years of life when appropriate. The results were expressed as odds ratios (OR) and 95% confidence 
intervals (95% CI). The FINETTI program was used to evaluate the Hardy–Weinberg equilibrium (HWE) of the 
studied TLR9 and TLR10 alleles studied.
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